Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-sectional, Multi-regional Study to Demonstrate Reduction in Exposure to Key Toxicants, Oxidative Stress, and Inflammation Following at Least 2 Years of Tobacco Heating System (THS) Use Compared to Cigarette Smoking

NCT05385055 is registered in ClinicalTrials.gov with Philip Morris Products S.A. as lead sponsor.

NCT NCT05385055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05385055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-sectional, Multi-regional Study to Demonstrate Reduction in Exposure to Key Toxicants, Oxidative Stress, and Inflammation Following at Least 2 Years of Tobacco Heating System (THS) Use Compared to Cigarette Smoking
Lead sponsor
Philip Morris Products S.A.
Phase
Observational
Overall status
Completed
Start date
June 13, 2022
Completion date
April 23, 2024
Enrollment
974 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation, oxidative stress, smoking, smoking abstinence